Quality and risk management
Hôpital Privé Sud Corse is strongly committed to continuous improvement in the quality and safety of care.
The main thrusts of our quality policy
The quality and safety drive is an integral part of the hospital's management and culture, and involves medical and non-medical professionals, as well as patients and their representatives.
- Improving the medical and non-medical service provided to patients;
- To be able to provide patients with quality care and services;
- Publish the results of the various assessment procedures carried out on our establishment, including the certification reports, which can be consulted at www.has-sante.fr ;
- Display the results of the HQSI (Healthcare Quality and Safety Indicators) in the hospital (available on the Scope Santé website: www.scopesante.fr);
- Enable the various bodies represented to provide technical support;
- Involve representatives of users and patient associations in the life of our establishment, so that they can facilitate patient expression and promote dialogue with healthcare professionals;
- Involving our establishment in the Haute Autorité de Santé (HAS) evaluation process.
A certified process
The clinic regularly undergoes Haute Autorité de Santé (HAS) certification procedures.
It measures the quality of its healthcare provision using a number of indicators set up by the Ministry of Health for each public and private health establishment, including :
- keeping patient records,
- combating hospital-acquired infections,
- inpatient satisfaction using the E-SATIS indicator.
All the results of these indicators are available on the website HAS Santé.
The aim of the certification process implemented by the French National Authority for Health (HAS) is to assess the quality and safety of the care and services provided by healthcare establishments. In particular, it takes into account their internal organisation and patient satisfaction.
Health authorities
CLAN (Comité Liaison Alimentaire Nutrition - Food and Nutrition Liaison Committee)
It is a consultative body whose opinions and proposals help to improve the nutritional care of patients and the quality of catering services.
COVIR (Vigilance and Risk Management Committee)
This committee develops a risk management programme and coordinates the various regulatory health monitoring systems:
Material vigilance : monitoring incidents or risks of incidents resulting from the use of medical devices.
Haemovigilance : set of procedures organised from the collection of blood and its components to the follow-up of recipients with a view to collecting and evaluating information on unexpected or undesirable effects resulting from the therapeutic use of labile blood products and preventing their occurrence.
This vigilance is the subject of work by a specific body: CSTH (Transfusion Safety and Haemovigilance Committee) whose role is to contribute, through its studies and proposals, to improving the safety of patients receiving transfusions in the establishment.
Pharmacovigilance Adverse drug reaction (ADR): all the techniques used to identify, assess and prevent the risk of adverse reactions to medicinal products placed on the market.
Infectiovigilance : monitoring of nosocomial infections or any infectious episode, epidemic or otherwise, occurring in the clinic or during hospitalisation.
Identity vigilance :all the different processes for controlling patient identification at all stages of patient care, and for monitoring and preventing errors and risks associated with patient identification.
Radiovigilance : monitoring, assessment and prevention of events related to accidental or unintentional exposure to ionising radiation and likely to affect patient health. The reporting of significant radiation protection events should enable measures to be put in place to prevent similar events from occurring in the future and to promote good practice aimed at improving patient safety.
COMEDIMS (Committee on Sterile Medicines and Medical Devices)
Through its opinions, this committee helps to draw up the list of medicines and sterile medical devices whose use is recommended in the clinic. It also formulates recommendations on prescribing, proper use and combating drug-related iatrogenicity. An anti-infectives (antibiotics) commission is an integral part of this committee.
The CSSI (Nursing Services Commission)
This committee defines the general organisation of nursing care and monitors patients as part of a nursing care project. It conducts research in the field of nursing, regularly assesses nursing practices and draws up a nursing training plan.
The CLUD (Pain Control Committee)
It is responsible for coordinating all actions aimed at improving the organisation of pain management and palliative care across all departments (medicinal and non-medicinal resources, evaluation of practices, training).
The CLIN (Nosocomial Infection Control Committee)
It defines a policy of actions to prevent and monitor these infections, monitor the environment, train and inform professionals, and evaluate actions to combat nosocomial infections. These actions are implemented by the Operational Hygiene Team (EOH), made up of medical and nursing professionals.
The CSI (Information System Commission)
Its role is to define the clinic's information system computerisation policy, support users in using the tools and ensure the reliability and security of the information system.
The CSR Committee
The aim of this committee is to promote best practice in CSR and sustainable development within the clinic, by defining short-, medium- and long-term objectives and the means of implementing them.
The Identity and Vigilance Unit (CIV)
This body is responsible for defining and ensuring the application of the patient identification policy within the establishment. It draws up procedures, communicates with staff and external structures, provides the necessary training and monitors and assesses practices relating to identity vigilance.